Spectrum of practice in the routine management of cervical dystonia with abobotulinumtoxinA: findings from three prospective open-label observational studies

por Misra, Vijay P., Trosch, Richard M., Maisonobe, Pascal, Om, Savary
Publicado 2018

Impact of abobotulinumtoxinA on the clinical features of cervical dystonia in routine practice

por Trosch, Richard M., Misra, Vijay P., Maisonobe, Pascal, Om, Savary
Publicado 2020

Correction to: How satisfied are cervical dystonia patients after 3 years of botulinum toxin type A treatment? Results from a prospective, long-term observational study

por Colosimo, Carlo, Charles, David, Misra, Vijay P., Maisonobe, Pascal, Om, Savary
Publicado 2019

How satisfied are cervical dystonia patients after 3 years of botulinum toxin type A treatment? Results from a prospective, long-term observational study

por Colosimo, Carlo, Charles, David, Misra, Vijay P., Maisonobe, Pascal, Om, Savary
Publicado 2019

Correction to: Patient perspectives on the therapeutic profile of botulinum neurotoxin type A in cervical dystonia

por Comella, Cynthia, Ferreira, Joaquim J., Pain, Emilie, Azoulai, Marion, Om, Savary
Publicado 2020

Patient perspectives on the therapeutic profile of botulinum neurotoxin type A in cervical dystonia

por Comella, Cynthia, Ferreira, Joaquim J., Pain, Emilie, Azoulai, Marion, Om, Savary
Publicado 2020

INTEREST IN CD2, a global patient-centred study of long-term cervical dystonia treatment with botulinum toxin

por Misra, Vijay P., Colosimo, Carlo, Charles, David, Chung, Tae Mo, Maisonobe, Pascal, Om, Savary
Publicado 2017